Marcum Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$214K Buy
+492
New +$198K 0.02% 355
2024
Q4
Sell
-516
Closed -$268K 417
2024
Q3
$268K Sell
516
-39
-7% -$20.8K 0.02% 307
2024
Q2
$301K Hold
555
0.03% 275
2024
Q1
$288K Buy
555
+35
+7% +$17.4K 0.03% 276
2023
Q4
$245K Buy
+520
New +$240K 0.03% 297
2023
Q3
Sell
-458
Closed -$203K 382
2023
Q2
$203K Buy
+458
New +$211K 0.02% 333
2023
Q1
Sell
-429
Closed -$220K 410
2022
Q4
$220K Buy
+429
New +$218K 0.03% 294
2022
Q3
Sell
-455
Closed -$220K 384
2022
Q2
$220K Sell
455
-16
-3% -$7.92K 0.03% 286
2022
Q1
$231K Buy
471
+18
+4% +$8.23K 0.03% 296
2021
Q4
$210K Buy
+453
New +$191K 0.03% 320

Other funds holding ELV

Marcum Wealth's ELV Position: Q1 2025 in Review

Marcum Wealth opened a new position in Elevance Health (ELV) in Q1 2025: 492 shares worth $214K. The stake represents 0.02% of the portfolio and ranks #355 among its holdings. This is a return to the name: Marcum Wealth previously reported a position in ELV as recently as Q3 2024.

Marcum Wealth first reported a position in ELV in Q4 2021 and has held it in 10 quarters since. The position peaked at $301K in Q2 2024. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Marcum Wealth held 492 shares of Elevance Health worth $214K as of Q1 2025.
  • Elevance Health was a new Marcum Wealth position in Q1 2025.
  • Elevance Health made up 0.02% of Marcum Wealth's portfolio in Q1 2025, its #355 holding.
  • Marcum Wealth first reported a position in Elevance Health in Q4 2021 and has held it in 10 quarters since.
  • Marcum Wealth's Elevance Health position peaked at $301K in Q2 2024.
  • 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.